3653 — Morpho Income Statement
0.000.00%
Last trade - 00:00
- ¥10bn
- ¥7bn
- ¥2bn
- 48
- 12
- 93
- 50
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,608 | 2,073 | 1,731 | 1,997 | 2,383 |
Cost of Revenue | |||||
Gross Profit | 2,058 | 1,436 | 867 | 952 | 1,357 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,021 | 2,433 | 2,651 | 2,678 | 2,694 |
Operating Profit | 587 | -360 | -920 | -681 | -310 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 543 | -353 | -866 | -603 | -258 |
Provision for Income Taxes | |||||
Net Income After Taxes | 345 | -653 | -798 | -668 | -300 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 340 | -652 | -793 | -668 | -300 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 340 | -652 | -793 | -668 | -300 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 75.5 | -86.2 | -139 | -118 | -50.3 |
Dividends per Share |